Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
- Status
- COMPLETED
- Phase
- NA
Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
- Status
- COMPLETED
- Phase
- PHASE4
Validating PROMIS Instruments in Depression
- Status
- COMPLETED
- Phase
- N/A
Antidepressant Incomplete Response Depression
- Status
- COMPLETED
- Phase
- N/A
AZD6765 Severe Major Depressive Disorder (MDD) IV
- Status
- COMPLETED
- Phase
- PHASE2
Using Neuroimaging to Investigate Major Depressive Disorder
- Status
- COMPLETED
- Phase
- N/A
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
- Status
- COMPLETED
- Phase
- PHASE3
Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder
- Status
- TERMINATED
- Phase
- PHASE2
Linköping University Relational and Interpersonal Psychotherapy Project
- Status
- TERMINATED
- Phase
- PHASE2
Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Electroencephalography (EEG) Biomarkers of Response in Depression
- Status
- COMPLETED
- Phase
- PHASE4
Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
- Status
- COMPLETED
- Phase
- PHASE1
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
- Status
- COMPLETED
- Phase
- PHASE2
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
- Status
- COMPLETED
- Phase
- PHASE2